Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Saranya Panichaporn, Wanwisa Chanapai, Ananya Srisomnuek, Phakhamon Thaweeratthakul & Wanruchada Katchamart. (2022) Validity and Reliability of the Thai Version of the 19-Item Compliance-Questionnaire-Rheumatology. Patient Preference and Adherence 16, pages 2149-2158.
Read now
Read now
Fabio Efficace & Francesco Cottone. (2019) Time for patient reported outcomes assessment in routine hematology practice: the case of chronic myeloid leukemia. Expert Review of Hematology 12:1, pages 1-3.
Read now
Read now
Bee Kim Tan, Seng Beng Tan, Li-Chia Chen, Kian Meng Chang, Siew Siang Chua, Sharmini Balashanker, Habiba Nazeera Begum Kamarul Jaman, Syed Carlo Edmund & Ping Chong Bee. (2017) Medication-related issues associated with adherence to long-term tyrosine kinase inhibitors for controlling chronic myeloid leukemia: a qualitative study. Patient Preference and Adherence 11, pages 1027-1034.
Read now
Read now
Elena Labrador Barba, Marta Rodríguez de Miguel, Antonio Hernández-Mijares, Francisco Javier Alonso-Moreno, Maria Luisa Orera Peña, Susana Aceituno & María José Faus Dader. (2017) Medication adherence and persistence in type 2 diabetes mellitus: perspectives of patients, physicians and pharmacists on the Spanish health care system. Patient Preference and Adherence 11, pages 707-718.
Read now
Read now
Federico De Marchi, Marta Medeot, Renato Fanin & Mario Tiribelli. (2017) How could patient reported outcomes improve patient management in chronic myeloid leukemia?. Expert Review of Hematology 10:1, pages 9-14.
Read now
Read now
Yuji Liguori, Katsuhito Murase & Misako Hamamura. (2016) Differences between patient and physician opinions on adherence to medication for hypertension and diabetes mellitus. Current Medical Research and Opinion 32:9, pages 1539-1545.
Read now
Read now
Wen-Chuan Huang, Chung-Yu Chen, Shun-Jin Lin & Chao-Sung Chang. (2016) Medication adherence to oral anticancer drugs: systematic review. Expert Review of Anticancer Therapy 16:4, pages 423-432.
Read now
Read now
Meri Kekäle, Marikki Peltoniemi & Marja Airaksinen. (2015) Patient-reported adverse drug reactions and their influence on adherence and quality of life of chronic myeloid leukemia patients on per oral tyrosine kinase inhibitor treatment. Patient Preference and Adherence 9, pages 1733-1740.
Read now
Read now
Articles from other publishers (27)
Lynn Verweij, Geneviève I. C. G. Ector, Yolba Smit, Bas van Vlijmen, Bert A. van der Reijden, Rosella P. M. G. Hermens & Nicole M. A. Blijlevens. (2023) Effectiveness of digital care platform CMyLife for patients with chronic myeloid leukemia: results of a patient-preference trial. BMC Health Services Research 23:1.
Crossref
Crossref
Kirsi Kvarnström, Aleksi Westerholm, Marja SA Airaksinen & Helena Liira. (2022) Why medicines are used differently from prescribed: a protocol for a prospective patient-oriented observational case study to investigate reasons for non-adherence in primary care. BMJ Open 12:12, pages e065363.
Crossref
Crossref
Hidehiro Sugisawa, Yumiko Shimizu, Tamaki Kumagai, Toshio Shinoda, Kanji Shishido & Yutaka Koda. (2022) Discordance between hemodialysis patients' reports and their physicians' estimates of adherence to dietary restrictions in Japan. Therapeutic Apheresis and Dialysis 26:6, pages 1156-1165.
Crossref
Crossref
Anna M. Mc Laughlin, Eduard Schmulenson, Olga Teplytska, Sebastian Zimmermann, Patrick Opitz, Stefanie L. Groenland, Alwin D. R. Huitema, Neeltje Steeghs, Lothar Müller, Stefan Fuxius, Gerald Illerhaus, Markus Joerger, Frank Mayer, Uwe Fuhr, Stefan Holdenrieder, Georg Hempel, Oliver Scherf-Clavel, Ulrich Jaehde & Charlotte Kloft. (2021) Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study Protocol. Cancers 13:24, pages 6281.
Crossref
Crossref
Trine Mechta Nielsen, Nina Schjerning, Gudrun Kaldan, Mads Hornum, Bo Feldt-Rasmussen & Thordis Thomsen. (2021) Practices and pitfalls in medication adherence in hemodialysis settings – a focus-group study of health care professionals. BMC Nephrology 22:1.
Crossref
Crossref
Susan L Baumgartner, D Eric Buffkin Jr, Elise Rukavina, Jason Jones, Elizabeth Weiler & Tony C Carnes. (2021) A Novel Digital Pill System for Medication Adherence Measurement and Reporting: Usability Validation Study. JMIR Human Factors 8:4, pages e30786.
Crossref
Crossref
P. V. Lipilkin, Yu. V. Shatokhin & A. A. Matsuga. (2020) Some characteristics of patients with myelodysplastic syndrome. Medical Herald of the South of Russia 11:4, pages 32-42.
Crossref
Crossref
Geneviève ICG Ector, Peter E Westerweel, Rosella PMG Hermens, Karin AE Braspenning, Barend CM Heeren, Oscar MF Vinck, Jan JM de Jong, Jeroen JWM Janssen & Nicole MA Blijlevens. (2020) The Development of a Web-Based, Patient-Centered Intervention for Patients With Chronic Myeloid Leukemia (CMyLife): Design Thinking Development Approach. Journal of Medical Internet Research 22:5, pages e15895.
Crossref
Crossref
Jolita Badarienė, Vilma Dženkevičiūtė, Egidija Rinkūnienė, Živilė Girkantaitė, Dovilė Šilinskienė, Eglė Skiauterytė, Milda Kovaitė, Antanas Mainelis, Ligita Ryliškytė, Alma Čypienė & Jūratė Barysienė. (2020) Does education degree affect the patient’s attitude towards the treatment after myocardial infarction?. Seminars in Cardiovascular Medicine 26:1, pages 1-6.
Crossref
Crossref
Alessia Fraccaroli, Florian Kaiser, Elisabeth Krull & Johanna Tischer. 2020. Onkologische Erkrankungen in der Hausarztpraxis. Onkologische Erkrankungen in der Hausarztpraxis
211
243
.
Nouh Harsha, Magor Papp, László Kőrösi, Árpád Czifra, Róza Ádány & János Sándor. (2019) Enhancing Primary Adherence to Prescribed Medications through an Organized Health Status Assessment-Based Extension of Primary Healthcare Services. International Journal of Environmental Research and Public Health 16:20, pages 3797.
Crossref
Crossref
Uday YanamandraPankaj MalhotraK.K. SahuYanamandra SushmaNeha SainiPooja ChauhanJasmeen GillDeepika RikhiAlka KhadwalGaurav PrakashDeepesh LadVikas SuriSavita KumariNeelam VarmaSubhash Varma. (2018) Variation in Adherence Measures to Imatinib Therapy. Journal of Global Oncology:4, pages 1-10.
Crossref
Crossref
Christel C. L. M. Boons, Lorette Harbers, Lonneke Timmers, Jan de Jong, Eleonora L. Swart, N. Harry Hendrikse, Jeroen J. W. M. Janssen & Jacqueline G. Hugtenburg. (2018) Needs for information and reasons for (non)adherence in chronic myeloid leukaemia: Be aware of social activities disturbing daily routines. European Journal of Haematology 101:5, pages 643-653.
Crossref
Crossref
Sandra Cuellar, Michael Vozniak, Jill Rhodes, Nicholas Forcello & Daniel Olszta. (2017) BCR-ABL1 tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia. Journal of Oncology Pharmacy Practice 24:6, pages 433-452.
Crossref
Crossref
Heini Kari, Hanna Kortejärvi, Marja Airaksinen & Raisa Laaksonen. (2018) Patient involvement is essential in identifying drug-related problems. British Journal of Clinical Pharmacology 84:9, pages 2048-2058.
Crossref
Crossref
Yu-Fen Tsai, Wen-Chuan Huang, Shih-Feng Cho, Hui-Hua Hsiao, Yi-Chang Liu, Sheng-Fung Lin, Ta-Chih Liu & Chao-Sung Chang. (2018) Side effects and medication adherence of tyrosine kinase inhibitors for patients with chronic myeloid leukemia in Taiwan. Medicine 97:26, pages e11322.
Crossref
Crossref
Tae Hee Lee, Mi Sun Sung, Hwan Heo & Sang Woo Park. (2018) Association between meibomian gland dysfunction and compliance of topical prostaglandin analogs in patients with normal tension glaucoma. PLOS ONE 13:1, pages e0191398.
Crossref
Crossref
Jan Geissler, Giora Sharf, Felice Bombaci, Mina Daban, Jan De Jong, Tony Gavin, Jana Pelouchova, Euzebiusz Dziwinski, Joerg Hasford & Verena Sophia Hoffmann. (2017) Factors influencing adherence in CML and ways to improvement: Results of a patient-driven survey of 2546 patients in 63 countries. Journal of Cancer Research and Clinical Oncology 143:7, pages 1167-1176.
Crossref
Crossref
Tomasz Sacha, Joanna Góra-Tybor, Ewa Wąsak-Szulkowska, Sławomira Kyrcz-Krzemień, Ewa Mędraś, Rafał Becht, Grażyna Bober, Aneta Kotowska, Joanna Wącław & Andrzej Hellmann. (2017) Quality of Life and Adherence to Therapy in Patients With Chronic Myeloid Leukemia Treated With Nilotinib as a Second-Line Therapy: A Multicenter Prospective Observational Study. Clinical Lymphoma Myeloma and Leukemia 17:5, pages 283-295.
Crossref
Crossref
Michelle Normen, Surendran Veeraiah & Prasanth Ganesan. (2017) Living with chronic myeloid leukemia in India-an exploratory study. Psycho-Oncology 26:5, pages 711-714.
Crossref
Crossref
Fabio Efficace & Laura Cannella. (2016) The value of quality of life assessment in chronic myeloid leukemia patients receiving tyrosine kinase inhibitors. Hematology 2016:1, pages 170-179.
Crossref
Crossref
Blaise Felix Faye, Nata Dieng, Moussa Seck, Macoura Gadji, Youssou Bamar Gueye, Diariatou Sy, Sokhna Aissatou Toure, Abibatou Sall, Awa Oumar Toure, Tandakha Ndiaye Dieye & Saliou Diop. (2016) Pattern of chronic myeloid leukemia in the imatinib era in a Sub-Saharan African setting. Annals of Hematology 95:10, pages 1603-1610.
Crossref
Crossref
Meri Kekäle, Tim Söderlund, Perttu Koskenvesa, Kimmo Talvensaari & Marja Airaksinen. (2016) Impact of tailored patient education on adherence of patients with chronic myeloid leukaemia to tyrosine kinase inhibitors: a randomized multicentre intervention study. Journal of Advanced Nursing 72:9, pages 2196-2206.
Crossref
Crossref
Qian Jiang, Zheng-Chen Liu, Song-Xin Zhang & Robert Peter Gale. (2016) Young age and high cost are associated with future preference for stopping tyrosine kinase inhibitor therapy in Chinese with chronic myeloid leukemia. Journal of Cancer Research and Clinical Oncology 142:7, pages 1539-1547.
Crossref
Crossref
Radhika Unnikrishnan, Surendran Veeraiah, Samson Mani, Rejiv Rajendranath, Swaminathan Rajaraman, Grace Sahaya Vidhubala Elangovan, Venkatraman Radhakrishnan, Trivadi S. Ganesan, Tenali G. Sagar & Prasanth Ganesan. (2016) Comprehensive Evaluation of Adherence to Therapy, Its Associations, and Its Implications in Patients With Chronic Myeloid Leukemia Receiving Imatinib. Clinical Lymphoma Myeloma and Leukemia 16:6, pages 366-371.e3.
Crossref
Crossref
Mathieu Verbrugghe, Veerle Duprez, Dimitri Beeckman, Mieke Grypdonck, Marijke Quaghebeur, Caroline Verschueren, Sofie Verhaeghe & Ann Van Hecke. (2016) Factors Influencing Adherence in Cancer Patients Taking Oral Tyrosine Kinase Inhibitors. Cancer Nursing 39:2, pages 153-162.
Crossref
Crossref
Selma Pabst, Anna Bertram, Tanja Zimmermann, Mario Schiffer & Martina de Zwaan. (2015) Physician reported adherence to immunosuppressants in renal transplant patients: Prevalence, agreement, and correlates. Journal of Psychosomatic Research 79:5, pages 364-371.
Crossref
Crossref